# Tolerance, Efficacy, revAlidation, Myostim

> **NCT04684771** · NA · COMPLETED · sponsor: **Alternativa International S.A** · enrollment: 35 (actual)

## Conditions studied

- Anterior Cruciate Ligament Rupture

## Interventions

- **DIETARY_SUPPLEMENT:** MYOSTIM®
- **DIETARY_SUPPLEMENT:** PLACEBO

## Key facts

- **NCT ID:** NCT04684771
- **Lead sponsor:** Alternativa International S.A
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-23
- **Primary completion:** 2017-07-27
- **Final completion:** 2017-12-31
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2020-12-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04684771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04684771, "Tolerance, Efficacy, revAlidation, Myostim". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT04684771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*